Data search
Results for MligTC455_15160
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_15160 | 11 | 0.23 | Mlig455_024917 | Neo: - Age: - |
Mlig455_024917 {REF} {Length: 773} {TRANSSPLICED} {RNA1310_98042} |
Cumulative graph for MligTC455_15160
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | - | - | - | - | |
| RegionR2 | - | - | - | - | |
| RegionR3 | - | - | - | - | |
| RegionR4 | - | - | - | - | |
| RegionR5 | - | - | - | - | |
| RegionR6 | - | - | - | - | |
| RegionR7 | - | - | - | - | |
| RegionR8 | - | - | - | - |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | - | - | - | - | |
| RegenerationR2 | - | - | - | - | |
| RegenerationR3 | - | - | - | - | |
| RegenerationR4 | - | - | - | - | |
| RegenerationR5 | - | - | - | - | |
| RegenerationR6 | - | - | - | - | |
| RegenerationBL | - | - | - | - | |
| RegenerationTP | - | - | - | - |
Genes with expression patterns similar to MligTC455_15160
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_12355 | 27 | 0.56 | Mlig455_024618 | Neo: - Age: - |
CHRNA3 | 1 | - | - | 1.000 | - | - | - | Mlig455_024618 {REF} {Length: 2865} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=270.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=246.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [RH, Score=432, Expect=7e-146]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [RH, Score=432, Expect=5e-146]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [RH, Score=419, Expect=1e-140]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [RH, Score=427, Expect=6e-144]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [RH, Score=426, Expect=2e-143]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [RH, Score=418, Expect=1e-140]; ENSMUSG00000035200, Chrnb4, cholinergic receptor, nicotinic, beta polypeptide 4, [RH, Score=406, Expect=4e-136]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [RH, Score=524, Expect=0.0]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=459, Expect=4e-157]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [RH, Score=521, Expect=6e-180]} {RNA1509_36802} {RNA1310_50512} {RNA815_3014.1} |
| 2. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
| 3. | MligTC455_13493 | 28 | 0.58 | Mlig455_020299 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_020299 {REF} {Length: 568} {RNA1310_11315} {RNA815_53929} | |
| 4. | MligTC455_15134 | 15 | 0.31 | Mlig455_000804 | Neo: - Age: - |
CNGA3 | 1 | - | - | 1.000 | - | - | - | Mlig455_000804 {REF} {Length: 2294} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.8]; Ion transport protein [PF00520.33, score=39.4]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=351, Expect=2e-113]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=344, Expect=2e-110]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=340, Expect=2e-109]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=352, Expect=9e-115]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=342, Expect=7e-110]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=338, Expect=9e-109]} {Dmel: FBgn0259145, CG42260, [Score=463, Expect=1e-153]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=281, Expect=1e-86]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=343, Expect=2e-111]} {RNA1310_120793} {RNA815_25814} |
| 5. | MligTC455_15160 | 11 | 0.23 | Mlig455_024917 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_024917 {REF} {Length: 773} {TRANSSPLICED} {RNA1310_98042} | |
| 6. | MligTC455_18788 | 27 | 0.57 | Mlig455_040989, Mlig455_040991 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_040989 {REF} {Length: 1277} {RNA1509_56938} {RNA1310_39299} {RNA815_53904} Mlig455_040991 {REF} {Length: 1852} {RNA1509_56938} {RNA1310_34736} {RNA815_16785.1} |
|
| 7. | MligTC455_36252 | 20 | 0.42 | Mlig455_050668 | Neo: - Age: - |
PRKAR2B | 1 | - | - | 1.000 | - | - | - | Mlig455_050668 {REF} {Length: 1234} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=45.2]} {Human: ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=93.2, Expect=7e-21]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=96.3, Expect=3e-22]} {Smed: dd_Smed_v6_1362_0_1, dd_Smed_v6_1362_0_1, [Score=87.8, Expect=2e-19]} |
| 8. | MligTC455_54226 | 52 | 1.09 | Mlig455_037435, Mlig455_037458 | Neo: - Age: - |
NETO2 | 1 | - | - | 1.000 | - | - | - | Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111} Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111} |
| 9. | MligTC455_05874 | 5 | 0.11 | Mlig455_049976 | Neo: - Age: - |
0.998 | - | - | 0.998 | - | - | - | Mlig455_049976 {REF} {Length: 389} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_109621} | |
| 10. | MligTC455_41475 | 43 | 0.89 | Mlig455_021663, Mlig455_021712 | Neo: - Age: - |
0.998 | - | - | 0.998 | - | - | - | Mlig455_021663 {REF} {Length: 486} {NoTransDecoderORF} {RNA1310_96898} Mlig455_021712 {REF} {Length: 812} {NoTransDecoderORF} {RNA1310_96898} |
|
| 11. | MligTC455_49949 | 46 | 0.95 | Mlig455_069056 | Neo: - Age: - |
ASIC1 | 0.998 | - | - | 0.998 | - | - | - | Mlig455_069056 {REF} {Length: 2381} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.6]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.2, Expect=2e-08]; ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=76.6, Expect=2e-14]} {Smed: dd_Smed_v6_12037_0_1, dd_Smed_v6_12037_0_1, [Score=94.4, Expect=4e-20]} {RNA1509_44792} {RNA1310_8631} {RNA815_5782} |
| 12. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.991 | - | - | 0.991 | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
| 13. | MligTC455_10386 | 40 | 0.84 | Mlig455_016460, Mlig455_016526, Mlig455_049813 | Neo: - Age: Up-Down-Down |
CHRNA2, CHRNA6 | 0.989 | - | - | 0.989 | - | - | - | Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177} |
| 14. | MligTC455_00524 | 6 | 0.12 | Mlig455_035116 | Neo: - Age: - |
0.988 | - | - | 0.988 | - | - | - | Mlig455_035116 {REF} {Length: 886} {NoTransDecoderORF} | |
| 15. | MligTC455_11476 | 26 | 0.54 | Mlig455_035212 | Neo: - Age: - |
0.988 | - | - | 0.988 | - | - | - | Mlig455_035212 {REF} {Length: 1374} {RNA1310_88897} {RNA815_51066} | |
| 16. | MligTC455_39681 | 136 | 2.83 | Mlig455_045908, Mlig455_045958, Mlig455_063327 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.624 Region-enriched R2: 4.082/0.00717 |
CASP1, CASP7 | 0.988 | - | - | 0.988 | - | - | - | Mlig455_045908 {REF} {Length: 1556} {NoTransDecoderORF} {RNA1310_115705} {RNA815_46116} Mlig455_045958 {REF} {Length: 1362} {Pfam: Caspase domain [PF00656.24, score=68.0]} {Human: ENSG00000165806, CASP7, caspase 7, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=58.9, Expect=1e-09]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=53.1, Expect=6e-08]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=49.7, Expect=4e-07]} {RNA1310_50397} {RNA815_46116} Mlig455_063327 {REF} {Length: 3941} {Pfam: Caspase domain [PF00656.24, score=81.3]} {Human: ENSG00000137752, CASP1, caspase 1, [Score=79.7, Expect=1e-15]} {Mouse: ENSMUSG00000025888, Casp1, caspase 1, [Score=82.8, Expect=1e-16]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=63.2, Expect=2e-10]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=75.9, Expect=6e-15]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=73.9, Expect=1e-14]} {RNA1509_50041} {RNA1310_2539.1} {RNA815_252.1} |
| 17. | MligTC455_27078 | 22 | 0.46 | Mlig455_028337, Mlig455_066176 | Neo: - Age: - |
0.987 | - | - | 0.987 | - | - | - | Mlig455_028337 {REF} {Length: 887} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083} Mlig455_066176 {REF} {Length: 883} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083} |
|
| 18. | MligTC455_33913 | 32 | 0.66 | Mlig455_047326 | Neo: - Age: - |
SPON1 | 0.986 | - | - | 0.986 | - | - | - | Mlig455_047326 {REF} {Length: 2405} {Pfam: Spondin_N [PF06468.15, score=98.6]} {Human: ENSG00000262655, SPON1, spondin 1, [Score=117, Expect=1e-27]} {Mouse: ENSMUSG00000038156, Spon1, spondin 1, (f-spondin) extracellular matrix protein, [Score=115, Expect=4e-27]} {Dmel: FBgn0033710, CG17739, [Score=105, Expect=3e-24]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=83.6, Expect=5e-17]} {Smed: dd_Smed_v6_2400_0_1, dd_Smed_v6_2400_0_1, [Score=83.6, Expect=4e-17]} {RNA1509_30850} {RNA1310_29306} {RNA815_50316} |
| 19. | MligTC455_37794 | 20 | 0.42 | Mlig455_017854, Mlig455_047876 | Neo: - Age: - |
0.986 | - | - | 0.986 | - | - | - | Mlig455_017854 {REF} {Length: 3779} {NoTransDecoderORF} {RNA1509_51255} {RNA1310_84895} {RNA815_39433} Mlig455_047876 {REF} {Length: 3089} {NoTransDecoderORF} {RNA1310_84895} |
|
| 20. | MligTC455_24197 | 48 | 1 | Mlig455_062645 | Neo: - Age: - |
KCNH7 | 0.981 | - | - | 0.981 | - | - | - | Mlig455_062645 {REF} {Length: 4615} {Pfam: Ion transport protein [PF00520.33, score=125.5]; Cyclic nucleotide-binding domain [PF00027.31, score=51.0]; Ion channel [PF07885.18, score=45.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=841, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=818, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=840, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=816, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=805, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=780, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=764, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [RH, Score=841, Expect=0.0]} {RNA1509_16542} {RNA1310_43827} {RNA815_26448} |
| 21. | MligTC455_43084 | 5 | 0.11 | Mlig455_035337 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_035337 {REF} {Length: 1065} {Pfam: Lectin C-type domain [PF00059.23, score=29.5]} {Smed: dd_Smed_v6_38541_0_2, dd_Smed_v6_38541_0_2, [Score=47.0, Expect=2e-06]} {RNA1509_45080} {RNA1310_133134} | |
| 22. | MligTC455_43829 | 45 | 0.95 | Mlig455_008872, Mlig455_008973 | Neo: - Age: Down-Up-Up |
TLL1 | 0.979 | - | - | 0.979 | - | - | - | Mlig455_008872 {REF} {Length: 3395} {Pfam: CUB domain [PF00431.22, score=147.6]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=92.8, Expect=1e-18]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=91.3, Expect=3e-18]} {Dmel: FBgn0261262, CG42613, [Score=102, Expect=9e-22]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=79.0, Expect=9e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [Score=265, Expect=1e-76]} {RNA1509_49507} {RNA1310_6026} {RNA815_27015} Mlig455_008973 {REF} {Length: 2985} {Pfam: CUB domain [PF00431.22, score=149.2]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=90.5, Expect=7e-18]; ENSG00000107611, CUBN, cubilin, [Score=86.3, Expect=2e-16]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=89.0, Expect=2e-17]} {Dmel: FBgn0261262, CG42613, [Score=101, Expect=1e-21]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=81.6, Expect=1e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [Score=267, Expect=2e-77]} {RNA1509_49507, RNA1509_572} {RNA1310_6026, RNA1509_49507, RNA1509_572} {RNA1509_49507, RNA1509_572, RNA815_27015} |
| 23. | MligTC455_45050 | 55 | 1.14 | Mlig455_067805 | Neo: - Age: - |
ADSL | 0.973 | - | - | 0.973 | - | - | - | Mlig455_067805 {REF} {Length: 3003} {TRANSSPLICED} {Pfam: Lyase [PF00206.22, score=80.8]} {Human: ENSG00000239900, ADSL, adenylosuccinate lyase, [Score=447, Expect=2e-155]} {Mouse: ENSMUSG00000022407, Adsl, adenylosuccinate lyase, [Score=446, Expect=3e-155]} {Dmel: FBgn0038467, AdSL, Adenylosuccinate Lyase, [Score=431, Expect=1e-148]} {Celegans: WBGene00011064, adsl-1, Adenylosuccinate lyase, [Score=314, Expect=2e-104]} {Smed: dd_Smed_v6_2280_0_1, dd_Smed_v6_2280_0_1, [Score=416, Expect=4e-143]} {RNA1509_16456} {RNA1310_14851} {RNA815_12501} |
| 24. | MligTC455_43783 | 8 | 0.17 | Mlig455_018589 | Neo: - Age: - |
0.968 | - | - | 0.968 | - | - | - | Mlig455_018589 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=54.3]} | |
| 25. | MligTC455_09573 | 9 | 0.18 | Mlig455_034666 | Neo: - Age: - |
0.958 | - | - | 0.958 | - | - | - | Mlig455_034666 {REF} {Length: 444} {NoTransDecoderORF} {RNA1310_102145.2} | |
| 26. | MligTC455_15449 | 384 | 7.99 | Mlig455_043360 | Neo: - Age: - |
0.954 | - | - | 0.954 | - | - | - | Mlig455_043360 {REF} {Length: 1602} {NoTransDecoderORF} {RNA1509_38319} {RNA1310_35989.1} {RNA815_36673} | |
| 27. | MligTC455_23809 | 119 | 2.47 | Mlig455_065200 | Neo: - Age: - |
0.953 | - | - | 0.953 | - | - | - | Mlig455_065200 {REF} {Length: 2060} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=33.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042} |